Leslie Shaw to Digoxin
This is a "connection" page, showing publications Leslie Shaw has written about Digoxin.
Connection Strength
0.470
-
Spinler SA, Al-Jazairi AS, Cheng JW, Kapoor S, Kobrin S, Shaw L. Predictive performance study of two digoxin assays in subjects with various degrees of renal function. Ther Drug Monit. 2000 Dec; 22(6):729-36.
Score: 0.179
-
Bernard DW, Bowman RL, Grimm FA, Wolf BA, Simson MB, Shaw LM. Nighttime dosing assures postdistribution sampling for therapeutic drug monitoring of digoxin. Clin Chem. 1996 Jan; 42(1):45-9.
Score: 0.128
-
Matzuk MM, Shlomchik M, Shaw LM. Making digoxin therapeutic drug monitoring more effective. Ther Drug Monit. 1991 May; 13(3):215-9.
Score: 0.092
-
Azzazy HM, Duh SH, Maturen A, Schaller E, Shaw L, Grimaldi R, Shock G, Christenson RH. Multicenter study of Abbott AxSYM Digoxin II assay and comparison with 6 methods for susceptibility to digoxin-like immunoreactive factors. Clin Chem. 1997 Sep; 43(9):1635-40.
Score: 0.036
-
Cheng JW, Charland SL, Shaw LM, Kobrin S, Goldfarb S, Stanek EJ, Spinler SA. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay. Pharmacotherapy. 1997 May-Jun; 17(3):584-90.
Score: 0.035